Remicade and Uniphyl drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Remicade (infliximab) and Uniphyl (theophylline). Common drug interactions include abdominal discomfort among females and pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Remicade and Uniphyl. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Remicade?

Remicade has active ingredients of infliximab. It is often used in crohn's disease. eHealthMe is studying from 224,011 Remicade users. Check the latest studies of Remicade.

What is Uniphyl?

Uniphyl has active ingredients of theophylline. eHealthMe is studying from 3,086 Uniphyl users. Check the latest studies of Uniphyl.



On Jul, 10, 2026

12 people who take Remicade and Uniphyl together, and have interactions are studied.

Remicade and Uniphyl drug interactions.

What are the common drug interactions of Remicade and Uniphyl, by gender? *:

female:

  1. Abdominal discomfort
  2. Abscess (pus)
  3. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  4. Asthenia (weakness)
  5. Bone disorder
  6. Chest discomfort
  7. Cough
  8. Decreased appetite
  9. Decreased interest
  10. Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)

male:

  1. Pneumonia
  2. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  3. Myalgia (muscle pain)
  4. Neoplasm malignant (cancer tumour)
  5. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  6. Kidney infection
  7. Neutropenia (an abnormally low number of neutrophils)
  8. Pneumococcal sepsis (pneumococcal sepsis is a serious medical condition where bacteria, specifically streptococcus pneumoniae)
  9. Renal failure chronic (long lasting kidney dysfunction)
  10. Pharyngoesophageal diverticulum

What are the common drug interactions of Remicade and Uniphyl, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Headache (pain in head)
  2. Hypoaesthesia oral (reduced sense of touch or sensation in mouth)
  3. Infusion related reaction
  4. Lip swelling
  5. Swelling

40-49:

n/a

50-59:

n/a

60+:

  1. Abdominal discomfort
  2. Abscess (pus)
  3. Eating disorder
  4. Escherichia infection (bacterial infection by escherichia coli)
  5. Fear
  6. Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
  7. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  8. Infection
  9. Lung disorder (lung disease)
  10. Malaise (a feeling of general discomfort or uneasiness)

What are the existing conditions these people have? *

  1. Asthma: 6 people, 50.00%
  2. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 41.67%
  3. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 16.67%
  4. Sinus Disorder (disease of sinus): 1 person, 8.33%
  5. Secretion Discharge: 1 person, 8.33%
  6. Prostatic Disorder: 1 person, 8.33%
  7. Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 1 person, 8.33%
  8. Gastric Disorder (disease of stomach): 1 person, 8.33%
  9. Eye Disorder: 1 person, 8.33%
  10. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Remicade and Uniphyl?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Remicade and Uniphyl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Remicade:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Uniphyl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Remicade and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Uniphyl and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on infliximab and theophylline (the active ingredients of Remicade and Uniphyl, respectively), and Remicade and Uniphyl (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: